
Therapeutic Area | MeSH |
|---|---|
| skin and connective tissue diseases | D017437 |
Tradename | Company | Number | Date | Products |
|---|---|---|---|---|
| AZELEX | Almirall | N-020428 RX | 1995-09-13 | 1 products, RLD, RS |
| FINACEA | LEO Pharma | N-021470 RX | 2002-12-24 | 1 products, RLD, RS |
| FINACEA | LEO Pharma | N-207071 RX | 2015-07-29 | 1 products, RLD, RS |
Brand Name | Status | Last Update |
|---|---|---|
| 10% azelaic acid acne cream | unapproved drug other | 2024-09-29 |
| 15% azelaic acid acne cream | unapproved drug other | 2024-09-29 |
| anubismed | OTC monograph final | 2023-09-05 |
| azelaic acid | ANDA | 2025-08-22 |
| azelaic acid 15% / niacinamide 4% | unapproved drug other | 2019-04-23 |
| azelaic acid 20% cream | C200263 | 2024-12-11 |
| azelaic acid gel | ANDA | 2025-09-04 |
| azelex | New Drug Application | 2024-03-04 |
| biboya azelaic acid tea tree acne cream | C200263 | 2024-08-15 |
| finacea | New Drug Application | 2025-01-06 |
Indication | Ontology | MeSH | ICD-10 |
|---|---|---|---|
| acne vulgaris | EFO_0003894 | D000152 | L70 |
| rosacea | — | D012393 | L71 |

| Drug common name | Azelaic acid |
| INN | azelaic acid |
| Description | Nonanedioic acid is an alpha,omega-dicarboxylic acid that is heptane substituted at positions 1 and 7 by carboxy groups. It has a role as an antibacterial agent, an antineoplastic agent, a dermatologic drug and a plant metabolite. It is a dicarboxylic fatty acid and an alpha,omega-dicarboxylic acid. It is a conjugate acid of an azelaate(2-) and an azelaate. |
| Classification | Small molecule |
| Drug class | — |
| Image (chem structure or protein) | ![]() |
| Structure (InChI/SMILES or Protein Sequence) | O=C(O)CCCCCCCC(=O)O |
| PDB | — |
| CAS-ID | 123-99-9 |
| RxCUI | — |
| ChEMBL ID | CHEMBL1238 |
| ChEBI ID | 48131 |
| PubChem CID | 2266 |
| DrugBank | DB00548 |
| UNII ID | F2VW3D43YT (ChemIDplus, GSRS) |






